Abstract
• Group B streptococcus and Escherichia coli account for most of the cases of neonatal early-onset bacterial sepsis. • Prevention of infection by maternal treatment is the main factor accounting for the decreased incidence of early-onset group B streptococcus sepsis. • Microbiologic cultures represent the mainstay for diagnosis of infection. • Management of the asymptomatic newborn at risk of infection because of maternal risk factors is in transition, with recent evidence supporting evaluation and treatment of a small proportion of asymptomatic infants. • Ampicillin and gentamicin are recommended as initial therapy in neonates with suspected bacterial sepsis. Treatment can then be narrowed appropriately on the basis of the results of antibiotic susceptibility studies.
| Original language | English (US) |
|---|---|
| Title of host publication | Avery's Diseases of the Newborn, Tenth Edition |
| Publisher | Elsevier |
| Pages | 553-565.e3 |
| ISBN (Electronic) | 9780323401395 |
| ISBN (Print) | 9780323401739 |
| DOIs | |
| State | Published - Jan 1 2017 |
Bibliographical note
Publisher Copyright:© 2018 Elsevier Inc. All rights reserved.
Keywords
- E coli
- Neonatal sepsis
- Risk factors for neonatal sepsis
- Streptococcus, Group B
- Treatment of neonatal sepsis
Fingerprint
Dive into the research topics of 'Newborn Sepsis and Meningitis'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS